Yu Shyr

Professor and Chair

Vanderbilt University Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Yu Shyr is a Professor and Chair at Vanderbilt University Medical Center in the United States. His research focuses on nascent transcriptome analysis, small ncRNA profiling, tumor immunotherapy interactions, and clinical trial methodologies. Recent publications cover a range of topics including cancer treatment outcomes, COVID-19 impacts in oncology patients, and novel therapeutic efficacy assessments in lung cancer.

Articles (15)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (19)

Andrew Portuguese

Assistant Professor

Fred Hutch Cancer Center

UNITED STATES

Yu Shyr

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

eNRSA: a faster and more powerful approach for nascent transcriptome analysis

EVPsort: An Atlas of Small ncRNA Profiling and Sorting in Extracellular Vesicles and Particles

A Large-Scale Meta-Analysis Reveals Positive Feedback between Macrophages and T Cells That Sensitizes Tumors to Immunotherapy

Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984

Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant Glioma

Comparative Treatment Outcomes for Idiopathic Subglottic Stenosis: 5-Year Update

Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium.

Power and sample sizes estimation in clinical trials with treatment switching in intention-to-treat analysis: a simulation study

Primary endpoints to assess the efficacy of novel therapeutic approaches in epidermal growth factor receptor-mutated, surgically resectable non-small cell lung cancer: A review

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.

A Mechanistic Clinical Trial Using ( R )- Versus (S )-Propafenone to Test RyR2 (Ryanodine Receptor) Inhibition for the Prevention of Atrial Fibrillation Induction

Preoperative and Postoperative Systemic Therapy for Operable Non–Small-Cell Lung Cancer

Immu-Mela: An open resource for exploring immunotherapy-related multidimensional genomic profiles in melanoma

MetaGSCA: A tool for meta-analysis of gene set differential coexpression

A domain damage index to prioritizing the pathogenicity of missense variants

Collaborators (19)

Andrew Portuguese

Ulka Vaishampayan

Joseph Kim

Sharon Phillips

Vicky Tagalakis

James Daniero

Jing Li

Fei Ye

Nora L. Nock

Nancy Davis

Leonard Appleman

Robbi Kupfer

Young Soo Rho

QI LIU

Douglas Van Daele

Na Tosha Gatson

Robert Coffey

Quanhu Sheng

Vinay Puduvalli

Make your next move.